ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
M

ASH Update on HCT for AML: Are We Starting to Refer AML Patients Earlier in CR1? Can PTCy Overcome HLA Barriers in Haplo-Identical HCT?

By ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases FEATURING Muhammad Umair Mushtaq
By ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases FEATURING Muhammad Umair Mushtaq
30 views
March 8, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
51:20
Jerry Spivak

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

13:04
Alexander Coltoff

Symptomatic Profiles of Patients With Polycythemia Vera: Implication…

37:12
Tisch Cancer Institute at Mount Sinai

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…

Feat. M. Metzger
10:44
Aaron Gerds

A Real-World Evaluation of the Association Between Elevated Blood Co…

10:27
Richard T. Silver

Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…

16:18
Masterclasses in Dermatology

Masterclasses from the Wards

Feat. S. Elman
40:05
Tisch Cancer Institute at Mount Sinai

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: M…

Feat. D. Tremblay, J. Mascarenhas, R. Sheppard, A. Shih, I. Sarami
09:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in AML

Feat. H. Kantarjian
25:01
Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Feat. R. Birhiray
20:32
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …

Feat. S. Kalayoglu Besisik
08:04
2nd SOHO Italian Conference

Cell Morphology in Acute Leukemias & Hematologic Malignancies: D…

Feat. G. Zini
19:10
Indy Hematology Review

Allo HSCT: Improvements in Transplant Outcomes, Myeloablative Vs. Re…

Feat. R. Childs
10:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: CC-486 Demonstrated Improvement in OS and RFS in Ma…

Feat. H. Male
11:18
Indy Hematology Review

Relapse After Allo HSCT - Treatment Strategies and Overview of Relat…

Feat. R. Childs
25:56
UChicago Annual Updates from ASH 2019

Inherited Predisposition to Myeloid Hematologic Malignancies: Why Do…

Feat. S. Feurstein